FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117806883> ?p ?o ?g. }

• W2117806883 endingPage "859" @default.
• W2117806883 startingPage "850" @default.
• W2117806883 abstract "Interferon alfa is a conservative and widely used alternative to bone marrow transplantation in treatment of patients with early chronic myeloid leukemia (CML). A meta-analysis was conducted to develop a reliable prognostic scoring system for estimation of survival of patients with CML treated with interferon alfa.Patients treated in prospective studies, including major randomized trials, were separated into learning and validation samples. Cox regression analysis and the minimum P-value approach were used to identify prognostic factors for patient survival and to discover groups in the learning sample with the greatest differences in survival. These findings were then validated by applying the new scoring system to patients in the validation sample.We collected data on 1573 patients who were participants in 14 studies involving 12 institutions; 1303 patients (learning sample, n = 981; validation sample, n = 322) were eligible for inclusion in this analysis, and their median survival time was 69 months (range, 1-117 months). Because two previously described prognostic scoring systems failed to discriminate risk groups satisfactorily, we developed a new scoring system that utilizes the following covariates: age, spleen size, blast count, platelet count, eosinophil count, and basophil count. Among 908 patients with complete data in the learning sample, three distinct risk groups were identified (median survival times of 98 months [n = 369; 40.6%], 65 months [n = 406; 44.7%], or 42 months [n = 133;14.6%]; two-sided logrank test, P< or =.0001). The ability of the new scoring system to discriminate these risk groups was confirmed by analysis of 285 patients with complete data in the validation sample (two-sided logrank test, P = .0002).A new prognostic scoring system for estimating survival of patients with CML treated with interferon alfa has been developed and validated through use of a large dataset." @default.
• W2117806883 created "2016-06-24" @default.
• W2117806883 creator A5016147985 @default.
• W2117806883 creator A5027757203 @default.
• W2117806883 creator A5032925254 @default.
• W2117806883 creator A5038000746 @default.
• W2117806883 creator A5042799541 @default.
• W2117806883 creator A5044224344 @default.
• W2117806883 creator A5066994665 @default.
• W2117806883 creator A5081114050 @default.
• W2117806883 creator A5086462994 @default.
• W2117806883 date "1998-06-03" @default.
• W2117806883 modified "2023-10-18" @default.
• W2117806883 title "A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Group" @default.
• W2117806883 cites W188630774 @default.
• W2117806883 cites W1928548710 @default.
• W2117806883 cites W1978391303 @default.
• W2117806883 cites W1989333836 @default.
• W2117806883 cites W1995341370 @default.
• W2117806883 cites W2028896946 @default.
• W2117806883 cites W2038750132 @default.
• W2117806883 cites W2038990138 @default.
• W2117806883 cites W2058190985 @default.
• W2117806883 cites W2269564684 @default.
• W2117806883 cites W229846343 @default.
• W2117806883 cites W2337277825 @default.
• W2117806883 cites W236820854 @default.
• W2117806883 cites W2438648923 @default.
• W2117806883 cites W2587781815 @default.
• W2117806883 cites W4237472716 @default.
• W2117806883 cites W861070113 @default.
• W2117806883 cites W977069352 @default.
• W2117806883 doi "https://doi.org/10.1093/jnci/90.11.850" @default.
• W2117806883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9625174" @default.
• W2117806883 hasPublicationYear "1998" @default.
• W2117806883 type Work @default.
• W2117806883 sameAs 2117806883 @default.
• W2117806883 citedByCount "734" @default.
• W2117806883 countsByYear W21178068832012 @default.
• W2117806883 countsByYear W21178068832013 @default.
• W2117806883 countsByYear W21178068832014 @default.
• W2117806883 countsByYear W21178068832015 @default.
• W2117806883 countsByYear W21178068832016 @default.
• W2117806883 countsByYear W21178068832017 @default.
• W2117806883 countsByYear W21178068832018 @default.
• W2117806883 countsByYear W21178068832019 @default.
• W2117806883 countsByYear W21178068832020 @default.
• W2117806883 countsByYear W21178068832021 @default.
• W2117806883 countsByYear W21178068832022 @default.
• W2117806883 countsByYear W21178068832023 @default.
• W2117806883 crossrefType "journal-article" @default.
• W2117806883 hasAuthorship W2117806883A5016147985 @default.
• W2117806883 hasAuthorship W2117806883A5027757203 @default.
• W2117806883 hasAuthorship W2117806883A5032925254 @default.
• W2117806883 hasAuthorship W2117806883A5038000746 @default.
• W2117806883 hasAuthorship W2117806883A5042799541 @default.
• W2117806883 hasAuthorship W2117806883A5044224344 @default.
• W2117806883 hasAuthorship W2117806883A5066994665 @default.
• W2117806883 hasAuthorship W2117806883A5081114050 @default.
• W2117806883 hasAuthorship W2117806883A5086462994 @default.
• W2117806883 hasBestOaLocation W21178068831 @default.
• W2117806883 hasConcept C10515644 @default.
• W2117806883 hasConcept C126322002 @default.
• W2117806883 hasConcept C143998085 @default.
• W2117806883 hasConcept C194409129 @default.
• W2117806883 hasConcept C203014093 @default.
• W2117806883 hasConcept C2776178377 @default.
• W2117806883 hasConcept C2778729363 @default.
• W2117806883 hasConcept C2909179924 @default.
• W2117806883 hasConcept C2911091166 @default.
• W2117806883 hasConcept C50382708 @default.
• W2117806883 hasConcept C66339696 @default.
• W2117806883 hasConcept C71924100 @default.
• W2117806883 hasConceptScore W2117806883C10515644 @default.
• W2117806883 hasConceptScore W2117806883C126322002 @default.
• W2117806883 hasConceptScore W2117806883C143998085 @default.
• W2117806883 hasConceptScore W2117806883C194409129 @default.
• W2117806883 hasConceptScore W2117806883C203014093 @default.
• W2117806883 hasConceptScore W2117806883C2776178377 @default.
• W2117806883 hasConceptScore W2117806883C2778729363 @default.
• W2117806883 hasConceptScore W2117806883C2909179924 @default.
• W2117806883 hasConceptScore W2117806883C2911091166 @default.
• W2117806883 hasConceptScore W2117806883C50382708 @default.
• W2117806883 hasConceptScore W2117806883C66339696 @default.
• W2117806883 hasConceptScore W2117806883C71924100 @default.
• W2117806883 hasIssue "11" @default.
• W2117806883 hasLocation W21178068831 @default.
• W2117806883 hasLocation W21178068832 @default.
• W2117806883 hasOpenAccess W2117806883 @default.
• W2117806883 hasPrimaryLocation W21178068831 @default.
• W2117806883 hasRelatedWork W1593574816 @default.
• W2117806883 hasRelatedWork W19333003 @default.
• W2117806883 hasRelatedWork W2117934342 @default.
• W2117806883 hasRelatedWork W2464905242 @default.
• W2117806883 hasRelatedWork W2912786681 @default.
• W2117806883 hasRelatedWork W3136232645 @default.
• W2117806883 hasRelatedWork W3164968239 @default.
• W2117806883 hasRelatedWork W4210863176 @default.

• next